ANIP - ANI Pharmaceuticals EPS misses by $0.14 beats on revenue
ANI Pharmaceuticals (ANIP): Q4 Non-GAAP EPS of $0.80 misses by $0.14; GAAP EPS of -$0.30 misses by $0.47.Revenue of $57.3M (+19.4% Y/Y) beats by $3.03M.Press Release
For further details see:
ANI Pharmaceuticals EPS misses by $0.14, beats on revenue